Resmed (RMD) Cash from Restructuring (2023)
Resmed posted quarterly Cash from Restructuring of $9.2 million for Q2 2023.
Resmed (RMD) has 1 years of Cash from Restructuring data on file, last reported at $9.2 million in Q2 2023.
- For the quarter ending Q2 2023, Cash from Restructuring changed N/A year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2025 stood at $9.2 million (changed N/A YoY), and the FY2024 full-year result was $33.2 million, up 262.2% from the prior year.
- Cash from Restructuring for Q2 2023 stood at $9.2 million.
- Across five years, Cash from Restructuring topped out at $9.2 million in Q2 2023 and bottomed at $9.2 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 9.18 Mn |